165 related articles for article (PubMed ID: 23749890)
1. Hedgehog targeting by cyclopamine suppresses head and neck squamous cell carcinoma and enhances chemotherapeutic effects.
Mozet C; Stoehr M; Dimitrova K; Dietz A; Wichmann G
Anticancer Res; 2013 Jun; 33(6):2415-24. PubMed ID: 23749890
[TBL] [Abstract][Full Text] [Related]
2. Reduced proliferation and colony formation of head and neck squamous cell carcinoma (HNSCC) after dual targeting of EGFR and hedgehog pathways.
Liebig H; Günther G; Kolb M; Mozet C; Boehm A; Dietz A; Wichmann G
Cancer Chemother Pharmacol; 2017 Feb; 79(2):411-420. PubMed ID: 28110457
[TBL] [Abstract][Full Text] [Related]
3. Simvastatin suppresses head and neck squamous cell carcinoma ex vivo and enhances the cytostatic effects of chemotherapeutics.
Stoehr M; Mozet C; Boehm A; Aigner A; Dietz A; Wichmann G
Cancer Chemother Pharmacol; 2014 Apr; 73(4):827-37. PubMed ID: 24562588
[TBL] [Abstract][Full Text] [Related]
4. Small interfering RNA targeting epidermal growth factor receptor enhances chemosensitivity to cisplatin, 5-fluorouracil and docetaxel in head and neck squamous cell carcinoma.
Nozawa H; Tadakuma T; Ono T; Sato M; Hiroi S; Masumoto K; Sato Y
Cancer Sci; 2006 Oct; 97(10):1115-24. PubMed ID: 16984384
[TBL] [Abstract][Full Text] [Related]
5. Single tissue samples from head and neck squamous cell carcinomas are representative regarding the entire tumor's chemosensitivity to cisplatin and docetaxel.
Wichmann G; Horn IS; Boehm A; Mozet C; Tschop K; Dollner R; Dietz A
Onkologie; 2009 May; 32(5):264-72. PubMed ID: 19420973
[TBL] [Abstract][Full Text] [Related]
6. Combined effects of lapatinib and cisplatin on colony formation of head and neck squamous cell carcinoma.
Schrader C; Boehm A; Reiche A; Dietz A; Mozet C; Wichmann G
Anticancer Res; 2012 Aug; 32(8):3191-9. PubMed ID: 22843892
[TBL] [Abstract][Full Text] [Related]
7. Stimulation by Monocyte Chemoattractant Protein-1 Modulates the Ex-vivo Colony Formation by Head and Neck Squamous Cell Carcinoma Cells.
Wichmann G; Körner C; Boehm A; Mozet C; Dietz A
Anticancer Res; 2015 Jul; 35(7):3917-24. PubMed ID: 26124338
[TBL] [Abstract][Full Text] [Related]
8. Gli-1 expression is associated with lymph node metastasis and tumor progression in esophageal squamous cell carcinoma.
Mori Y; Okumura T; Tsunoda S; Sakai Y; Shimada Y
Oncology; 2006; 70(5):378-89. PubMed ID: 17179732
[TBL] [Abstract][Full Text] [Related]
9. [Sonic hedgehog signaling enhanced the expression of histone demethylase, lysine-specific demethylase 8 in the head and neck squamous cell carcinoma cell line SCC-6].
Yin XN; Ma YS; Du J; Fan ZP
Zhonghua Kou Qiang Yi Xue Za Zhi; 2013 Feb; 48(2):77-80. PubMed ID: 23714058
[TBL] [Abstract][Full Text] [Related]
10. Hedgehog signaling drives radioresistance and stroma-driven tumor repopulation in head and neck squamous cancers.
Gan GN; Eagles J; Keysar SB; Wang G; Glogowska MJ; Altunbas C; Anderson RT; Le PN; Morton JJ; Frederick B; Raben D; Wang XJ; Jimeno A
Cancer Res; 2014 Dec; 74(23):7024-36. PubMed ID: 25297633
[TBL] [Abstract][Full Text] [Related]
11. Docetaxel associated pathways in cisplatin resistant head and neck squamous cell carcinoma: a pilot study.
Yoo GH; Lin HS; Iskander AJ; Piechocki MP; Oliver J; Kewson D; Lonardo F; Tainsky MA; Kim HR; Kim H; Ensley JF
Laryngoscope; 2005 Nov; 115(11):1938-46. PubMed ID: 16319602
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of the Hedgehog signalling pathway in head and neck squamous cell carcinoma.
Dimitrova K; Stoehr M; Dehghani F; Dietz A; Wichmann G; Bertolini J; Mozet C
Onkologie; 2013; 36(5):279-86. PubMed ID: 23689223
[TBL] [Abstract][Full Text] [Related]
13. Impact of the Smoothened inhibitor, IPI-926, on smoothened ciliary localization and Hedgehog pathway activity.
Peluso MO; Campbell VT; Harari JA; Tibbitts TT; Proctor JL; Whitebread N; Conley JM; White KF; Kutok JL; Read MA; McGovern K; Faia KL
PLoS One; 2014; 9(3):e90534. PubMed ID: 24608250
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of epithelial and stromal cells of head and neck squamous cell carcinomas in ex vivo chemoresponse.
Horn IS; Wichmann G; Mozet C; Dietz A; Dollner R; Tschöp K; Boehm A
Cancer Chemother Pharmacol; 2010 May; 65(6):1153-63. PubMed ID: 19771432
[TBL] [Abstract][Full Text] [Related]
15. STAT3 blockade enhances the efficacy of conventional chemotherapeutic agents by eradicating head neck stemloid cancer cell.
Bu LL; Zhao ZL; Liu JF; Ma SR; Huang CF; Liu B; Zhang WF; Sun ZJ
Oncotarget; 2015 Dec; 6(39):41944-58. PubMed ID: 26556875
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapeutic alteration of VEGF, PDGF and PDGFRα/β expression under 5-FU vs. docetaxel in HPV-transformed squamous cell carcinoma compared to HPV-negative HNSCC in vitro.
Aderhold C; Umbreit C; Faber A; Sauter A; Sommer JU; Birk R; Erben P; Hofheinz RD; Stern-Straeter J; Hörmann K; Schultz JD
Anticancer Res; 2013 May; 33(5):1951-61. PubMed ID: 23645743
[TBL] [Abstract][Full Text] [Related]
17. Tumor shrinkage by cyclopamine tartrate through inhibiting hedgehog signaling.
Fan Q; Gu D; He M; Liu H; Sheng T; Xie G; Li CX; Zhang X; Wainwright B; Garrossian A; Garrossian M; Gardner D; Xie J
Chin J Cancer; 2011 Jul; 30(7):472-81. PubMed ID: 21718593
[TBL] [Abstract][Full Text] [Related]
18. Combinatorial Effects of Curcumin with an Anti-Neoplastic Agent on Head and Neck Squamous Cell Carcinoma Through the Regulation of EGFR-ERK1/2 and Apoptotic Signaling Pathways.
Sivanantham B; Sethuraman S; Krishnan UM
ACS Comb Sci; 2016 Jan; 18(1):22-35. PubMed ID: 26505786
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of cytotoxic properties of a cyclopamine glucuronide prodrug in rat glioblastoma cells and tumors.
Bensalma S; Chadeneau C; Legigan T; Renoux B; Gaillard A; de Boisvilliers M; Pinet-Charvet C; Papot S; Muller JM
J Mol Neurosci; 2015 Jan; 55(1):51-61. PubMed ID: 25280457
[TBL] [Abstract][Full Text] [Related]
20. Butyrate response factor 1 enhances cisplatin sensitivity in human head and neck squamous cell carcinoma cell lines.
Lee SK; Kim SB; Kim JS; Moon CH; Han MS; Lee BJ; Chung DK; Min YJ; Park JH; Choi DH; Cho HR; Park SK; Park JW
Int J Cancer; 2005 Oct; 117(1):32-40. PubMed ID: 15880358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]